Ikeda, Kenji <br/><br/>
A long-term glycyrrhizin injection therapy reduces hepatocellular carcinogenesis rate in patients with interferon-resistant active chronic hepatitis C: a cohort study of 1249 patients.  [electronic resource] 

 -  Digestive diseases and sciences  Mar 2006 
 - 603-9 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article 
<br/><br/><label>ISSN: </label>0163-2116 
<br/><br/><label>Standard No.: </label>10.1007/s10620-006-3177-0  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Carcinoma, Hepatocellular--epidemiology<br/>Case-Control Studies<br/>Cohort Studies<br/>Dose-Response Relationship, Drug<br/>Drug Administration Schedule<br/>Drug Resistance<br/>Female<br/>Glycyrrhizic Acid--administration & dosage<br/>Hepatitis C, Chronic--drug therapy<br/>Humans<br/>Incidence<br/>Injections, Intravenous<br/>Interferon alpha-2<br/>Interferon-alpha--therapeutic use<br/>Liver Function Tests<br/>Liver Neoplasms--epidemiology<br/>Long-Term Care<br/>Male<br/>Middle Aged<br/>Multivariate Analysis<br/>Probability<br/>Prognosis<br/>Recombinant Proteins<br/>Retrospective Studies<br/>Risk Assessment<br/>Severity of Illness Index<br/>Treatment Outcome